G

GT Medical Technologies

HealthMedical DevicesB2B📍 United States

GT Medical Technologies develops innovative treatments for brain tumor patients, focusing on improving survival outcomes and quality of life. Their flagship product, GammaTile therapy, delivers immediate targeted radiation at the tumor site during surgery, aiming to reduce tumor regrowth and limit exposure to healthy brain tissue.

Total raised
$100M
tracked to date
Latest round
Series E
Jun 9, 2026
Known investors
6
led by Viking Global Investors

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United States.

Claim this profile →

🏆 Featured in Datapile’s Q2 2026 USA Funding Report

Read the Q2 2026 USA report →
Add this badge to your site
<a href="https://datapile.co/reports/q2-2026-usa-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 USA Funding Report</a>

Funding history

  1. 1
    $100MSeries EJun 9, 2026

    Led by Viking Global Investors

    Announcement ↗

Investors in GT Medical Technologies

Backers from this company's tracked funding rounds.

  • VViking Global InvestorsLead investorVC firm
  • MMVM PartnersVC firm
  • GGilde HealthcareVC firm
  • EEvidity Health CapitalVC firm
  • MMedtech Venture PartnersVC firm
  • FFemHealth VenturesVC firm

GT Medical Technologies in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile